Q4 2020 Holdings
Filed 2021-02-16 | 59 holdings | $805.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ALX Oncology Holdings Inc(ALXO) | Common | 00166B105 | $363.8M | 4,220,048 | 45.2% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $299.8M | 1,797,745 | 37.2% |
| Crinetics Pharmaceuticals Inc(CRNX) | Common | 22663K107 | $33.0M | 2,335,889 | 4.1% |
| Arcutis Biotherapeutics Inc(ARQT) | Common | 03969K108 | $24.4M | 867,170 | 3.0% |
| Celldex Therapeutics Inc(CLDX) | Common | 15117B202 | $22.6M | 1,291,875 | 2.8% |
| Arrowhead Pharmaceuticals Inc(ARWR) | Common | 04280A100 | $15.7M | 205,091 | 2.0% |
| Cytokinetics Inc(CYTK) | Common | 23282W605 | $14.5M | 700,000 | 1.8% |
| Aclaris Therapeutics, Inc.(ACRS) | Common | 00461U105 | $10.7M | 1,647,214 | 1.3% |
| Codexis, Inc(CDXS) | Common | 192005106 | $8.5M | 388,144 | 1.1% |
| Aurinia Pharmaceuticals Inc.(AUPH) | Common | 05156V102 | $6.9M | 500,732 | 0.9% |
| Atricure Inc(ATRC) | Common | 04963C209 | $3.6M | 64,573 | 0.4% |
| Harmony Biosciences Holdings Inc(HRMY) | Common | 413197104 | $163.9K | 4,534,341 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | Common | 87650L103 | $134.1K | 3,245,035 | 0.0% |
| New Frontier Health Corp | Ord Shs | G6461G106 | $123.0K | 14,300,000 | 0.0% |
| Aligos Therapeutics Inc | Common | 01626L105 | $98.1K | 3,547,030 | 0.0% |
| Genetron Holdings Ltd | ADS | 37186H100 | $88.8K | 6,339,860 | 0.0% |
| Amyris, Inc(AMRSEUR) | Common | 03236M200 | $81.3K | 13,161,847 | 0.0% |
| Legend Biotech Corp Sponsored(LEGN) | SPONSORED ADS | 52490G102 | $77.6K | 2,755,007 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | Common | 68062P106 | $59.6K | 1,238,575 | 0.0% |
| Iveric Bio Inc(OPHTEUR) | Common | 46583P102 | $41.2K | 5,966,527 | 0.0% |
| Sinovac Biotech Ltd.(SVA) | SHS | P8696W104 | $38.2K | 5,900,000 | 0.0% |
| Passage Bio Inc | Common | 702712100 | $38.0K | 1,487,038 | 0.0% |
| Nkarta Inc(NKTX) | Common | 65487U108 | $31.5K | 512,225 | 0.0% |
| KalVista Pharmaceuticals Inc.(KALV) | Common | 483497103 | $30.7K | 1,618,296 | 0.0% |
| Sierra Oncology, Inc | Common | 82640U404 | $30.7K | 1,917,074 | 0.0% |
| Kadmon Holdings Inc(KDMN) | Common | 48283N106 | $24.1K | 5,817,459 | 0.0% |
| Zai Lab Ltd ADR(ZLAB) | ADR | 98887Q104 | $23.7K | 175,000 | 0.0% |
| Avadel Pharmaceuticals PLC | ADR | 05337M104 | $23.6K | 3,526,093 | 0.0% |
| Essa Pharma Inc(EPIEUR) | Common | 29668H708 | $22.6K | 1,893,907 | 0.0% |
| Eiger BioPharmaceuticals Inc(CLDNEUR) | Common | 28249U105 | $22.0K | 1,791,257 | 0.0% |
| Verona Pharma PLC ADR(VRNA) | ADS | 925050106 | $21.3K | 3,048,507 | 0.0% |
| Zogenix Inc | Common | 98978L204 | $20.1K | 1,006,494 | 0.0% |
| Chinook Therapeutics Inc(290A) | Common | 16961L106 | $19.1K | 1,206,266 | 0.0% |
| Novavax Inc(NVAX) | Common | 670002401 | $17.6K | 157,487 | 0.0% |
| Kura Oncology Inc(KURA) | Common | 50127T109 | $17.2K | 525,262 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | Common | 517125100 | $17.1K | 799,662 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | Common | 77313F106 | $17.0K | 310,584 | 0.0% |
| Akero Therapeutics Inc(AKRO) | Common | 00973Y108 | $16.3K | 633,426 | 0.0% |
| Immunovant Inc(IMVT) | Common | 45258J102 | $16.1K | 347,662 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | ADS | 589492107 | $15.1K | 4,220,938 | 0.0% |
| Zymeworks Inc | Common | 98985W102 | $13.5K | 286,064 | 0.0% |
| Curis Inc(CRISEUR) | Common | 231269200 | $11.5K | 1,400,000 | 0.0% |
| Calliditas Therapeutics ADR | SPONSORED ADS | 13124Q106 | $10.5K | 311,030 | 0.0% |
| Poseida Therapeutics Inc(PSTXUSD) | Common | 73730P108 | $10.2K | 926,447 | 0.0% |
| Homology Medicines, Inc. | Common | 438083107 | $9.6K | 853,143 | 0.0% |
| Matinas Biopharma Hldgs Inc | Common | 576810105 | $8.8K | 6,451,612 | 0.0% |
| 10X Genomics Inc(TXG) | CL A Common | 88025U109 | $8.4K | 58,977 | 0.0% |
| Dyne Therapeutics Inc(DYN) | Common | 26818M108 | $6.6K | 315,000 | 0.0% |
| Orchard Therapeutics plc | ADS | 68570P101 | $5.7K | 1,325,736 | 0.0% |
| Kala Pharmaceuticals, Inc. | Common | 483119103 | $5.3K | 786,883 | 0.0% |